Literature DB >> 16444361

[Endocrine tumors associated to protein Gsalpha/Gi2alpha mutations].

Milena Gurgel Teles Bezerra1, Ana Claudia Latronico, Maria Candida B V Fragoso.   

Abstract

Many oncogenic mutations promote tumor growth by inducing autonomous activity of proteins that normally transmit proliferative signal initiated by extracellular factors. G proteins are a family of guanine nucleotide binding proteins, which are structurally homologous and widely distributed in eukaryotic cells. They are composed of three different subunits (alpha, beta e gamma). The alpha subunit, which contains the guanine nucleotide-binding site, is unique to each G protein. The G proteins couple an array of seven transmembrane receptors at the cell surface with a variety of intracellular effectors, which produce second messenger molecules. A subset of endocrine tumors, such as GH- or ACTH-secreting pituitary adenomas, functioning thyroid adenomas, adrenocortical and gonadal tumors were associated with somatic activating mutations in the highly conserved codons of the Gs (Arg201 and Gln227) and Gi (Arg179 and Gln205) proteins. These findings indicated that the G proteins play a role as oncogenes, contributing with the human endocrine tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16444361     DOI: 10.1590/s0004-27302005000500019

Source DB:  PubMed          Journal:  Arq Bras Endocrinol Metabol        ISSN: 0004-2730


  2 in total

1.  Systematic Analysis of Neurotransmitter Receptors in Human Breast Cancer Reveals a Strong Association With Outcome and Uncovers HTR6 as a Survival-Associated Gene Potentially Regulating the Immune Microenvironment.

Authors:  Wei Zhang; Lintai Li; Jianxuan Li; Haiyan Yu; Fengping Zheng; Bin Yan; Wanxia Cai; Yumei Chen; Lianghong Yin; Donge Tang; Yong Xu; Yong Dai
Journal:  Front Immunol       Date:  2022-03-10       Impact factor: 7.561

2.  Genetic analysis of a patient with coexisting acromegaly, thyroid papillary carcinoma and subcutaneous fibroma.

Authors:  Jingfang Liu; Xulei Tang; Jianguo Cheng; Liting Wang; Xiaomei Yang; Yan Wang
Journal:  Oncol Lett       Date:  2014-12-23       Impact factor: 2.967

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.